These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Severe adverse reaction to carbamazepine: significance of humoral and cellular reactions to the drug. Horneff G; Lenard HG; Wahn V Neuropediatrics; 1992 Oct; 23(5):272-5. PubMed ID: 1454149 [TBL] [Abstract][Full Text] [Related]
27. Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity. Houwerzijl J; De Gast GC; Nater JP; Esselink MT; Nieweg HO Clin Exp Immunol; 1977 Aug; 29(2):272-7. PubMed ID: 908175 [TBL] [Abstract][Full Text] [Related]
28. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055 [TBL] [Abstract][Full Text] [Related]
29. Anticonvulsant toxicity in vitro: possible role of arene oxides. Spielberg SP; Gordon GB; Blake DA; Mellits ED; Bross DS J Pharmacol Exp Ther; 1981 May; 217(2):386-9. PubMed ID: 7229980 [TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and management of drug allergy]. Muranaka M Naika; 1968 Feb; 21(2):286-94. PubMed ID: 4301009 [No Abstract] [Full Text] [Related]
32. [Generalized side effects with the use of carbamazepine]. Tijhuis GJ; Strijbos JH; van Ermen A; Offerman JJ; Dubois AE Ned Tijdschr Geneeskd; 1995 Nov; 139(44):2265-8. PubMed ID: 7501054 [TBL] [Abstract][Full Text] [Related]
33. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso. Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451 [TBL] [Abstract][Full Text] [Related]
34. Do arylhydroxylamine metabolites mediate idiosyncratic reactions associated with sulfonamides? Svensson CK Chem Res Toxicol; 2003 Sep; 16(9):1035-43. PubMed ID: 12971790 [No Abstract] [Full Text] [Related]
35. [Drug hypersensitivity in AIDS patients: report of a case]. Ribeiro LM; Pastorino AC; Grumach AS; Jacob CM Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(1):23-7. PubMed ID: 9334468 [TBL] [Abstract][Full Text] [Related]
36. Interferon-gamma production in the peripheral lymphocytes of a patient with carbamazepine hypersensitivity syndrome. Koga T; Kubota Y; Nakayama J Acta Derm Venereol; 2000; 80(1):73. PubMed ID: 10721852 [No Abstract] [Full Text] [Related]
37. A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes. Neuman MG; Malkiewicz IM; Shear NH Clin Biochem; 2000 Oct; 33(7):517-24. PubMed ID: 11124336 [TBL] [Abstract][Full Text] [Related]
38. Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Naisbitt DJ; Hough SJ; Gill HJ; Pirmohamed M; Kitteringham NR; Park BK Br J Pharmacol; 1999 Mar; 126(6):1393-407. PubMed ID: 10217534 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone. Reilly TP; Bellevue FH; Woster PM; Svensson CK Biochem Pharmacol; 1998 Mar; 55(6):803-10. PubMed ID: 9586952 [TBL] [Abstract][Full Text] [Related]
40. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. Mauri-Hellweg D; Bettens F; Mauri D; Brander C; Hunziker T; Pichler WJ J Immunol; 1995 Jul; 155(1):462-72. PubMed ID: 7602118 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]